Patents by Inventor Judith Aronhime

Judith Aronhime has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240237649
    Abstract: The present invention provides crystalline forms of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2(1H)-one, and uses and processes of preparation thereof. The present invention also provides combinations, mixtures and compositions comprising the crystalline forms of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2(1H)-one, and uses and processes of preparation thereof.
    Type: Application
    Filed: May 4, 2022
    Publication date: July 18, 2024
    Applicant: Adama Makhteshim Ltd.
    Inventors: Stefano Luca Giaffreda, Enrico Modena, Cristina Ianni, Chiara Parise, Rotem Stella-Erez, Judith Aronhime, Gal Suez, Hanan Sertchook
  • Publication number: 20230057759
    Abstract: The present disclosure relates to a solid state form of Pyroxasulfone, processes for preparation thereof and agrochemical compositions thereof.
    Type: Application
    Filed: January 13, 2021
    Publication date: February 23, 2023
    Applicant: ADAMA AGAN LTD.
    Inventors: Judith Aronhime, Rotem Sella-Erez
  • Patent number: 10214553
    Abstract: The present disclosure encompasses solid state forms of Sofosbuvir, processes for their production, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: February 26, 2019
    Assignees: TEVA PHARMACEUTICALS INTERNATIONAL GMBH, RATIOPHARM GMBH
    Inventors: Wolfgang Albrecht, Judith Aronhime, Brijnath P. Chaurasia, Jens Geier, Richard Guserle, Julia Hrakovsky, Claudia Lauer, Ramkaran Prajapati, Vinod K. Kansal, Pavan V. Kumar, Hans-Juergen Mika, Siva Rama Krishna Muppalla, Marina Ratkaj, Roman Safonov, Dirk Schenk, Naveen C. Srivastav, Ralph Stefan, Ashish Tripathi
  • Patent number: 9718829
    Abstract: Provided are crystalline forms of N-[4-[2-(2-amino-4, 7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]ben-zoyl]-L-glutamic acid, pemetrexed diacid, and processes for the preparation thereof.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: August 1, 2017
    Assignee: Sicor Inc.
    Inventors: Jonathan Busolli, Nicola Diulgheroff, Csilla Nemethne Racz, Moran Pirkes, Alessandro Pontiroli, Marco Villa, Judith Aronhime
  • Publication number: 20170137453
    Abstract: The present disclosure encompasses solid state forms of Sofosbuvir, processes for their production, and pharmaceutical compositions thereof.
    Type: Application
    Filed: June 12, 2015
    Publication date: May 18, 2017
    Applicant: ratiopharm GmbH
    Inventors: Wolfgang ALBRECHT, Judith ARONHIME, Brijnath P. CHAURASIA, Jens GEIER, Richard GUSERLE, Julia HRAKOVSKY, Claudia LAUER, Ramkaran PRAJAPATI, Vinod K. KANSAL, Pavan V. KUMAR, Hans-Juergen MIKA, Siva Rama Krishna MUPPALLA, Marina RATKAJ, Roman SAFONOV, Dirk SCHENK, Naveen C. SRIVASTAV, Ralph STEFAN, Ashish TRIPATHI
  • Publication number: 20170129900
    Abstract: Provided are crystalline forms of N-[4-[2-(2-amino-4, 7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]ben-zoyl]-L-glutamic acid, pemetrexed diacid, and processes for the preparation thereof.
    Type: Application
    Filed: November 23, 2016
    Publication date: May 11, 2017
    Inventors: Jonathan Busolli, Nicola Diulgheroff, Csilla Nemethne Racz, Moran Pirkes, Alessandro Pontiroli, Marco Villa, Judith Aronhime
  • Patent number: 9562050
    Abstract: Provided are crystalline forms of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]ben-zoyl]-L-glutamic acid, pemetrexed diacid, and processes for the preparation thereof.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: February 7, 2017
    Assignee: Sicor, Inc.
    Inventors: Jonathan Busolli, Nicola Diulgheroff, Csilla Nemethne Racz, Moran Pirkes, Alessandro Pontiroli, Marco Villa, Judith Aronhime
  • Publication number: 20170015696
    Abstract: The present disclosure encompasses solid state forms of Sofosbuvir and pharmaceutical compositions thereof.
    Type: Application
    Filed: February 19, 2015
    Publication date: January 19, 2017
    Inventors: David Perez PALACIOS, Jens GEIER, Judith ARONHIME, Limor TESSLER-SHAMIS, Sigalit LEVI, Siva Rama Krishna MUPPALLA
  • Publication number: 20160002253
    Abstract: Provided are crystalline forms of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]ben-zoyl]-L-glutamic acid, pemetrexed diacid, and processes for the preparation thereof.
    Type: Application
    Filed: September 16, 2015
    Publication date: January 7, 2016
    Inventors: Jonathan Busolli, Nicola Diulgheroff, Csilla Nemethne Racz, Moran Pirkes, Alessandro Pontiroli, Marco Villa, Judith Aronhime
  • Patent number: 9156841
    Abstract: Provided are crystalline forms of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid, pemetrexed diacid, and processes for the preparation thereof.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: October 13, 2015
    Assignee: Sicor Inc.
    Inventors: Jonathan Busolli, Nicola Diulgheroff, Csilla Nemethne Racz, Moran Pirkes, Alessandro Pontiroli, Marco Villa, Judith Aronhime
  • Patent number: 9108962
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: August 18, 2015
    Assignee: Sicor, Inc.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • Publication number: 20140323515
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 30, 2014
    Inventors: Nicola DIULGHEROFF, Francesca SCARPITTA, Alessandro PONTIROLI, Adrienne KOVACSNE-MEZEI, Judith ARONHIME, Alexandr JEGOROV
  • Patent number: 8846926
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: September 30, 2014
    Assignee: Sicor Inc.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • Publication number: 20140057935
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: October 31, 2013
    Publication date: February 27, 2014
    Applicant: SCIOR INC.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexander Jegorov
  • Publication number: 20120165364
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: March 5, 2012
    Publication date: June 28, 2012
    Applicant: SICOR INC.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • Patent number: 8207361
    Abstract: The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: June 26, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sigalit Levi, Judith Aronhime, Tamas Koltai
  • Publication number: 20120108625
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: December 28, 2011
    Publication date: May 3, 2012
    Applicant: SICOR INC.
    Inventors: Nicola DIULGHEROFF, Francesca SCARPITTA, Alessandro PONTIROLI, Adrienne KOVACSNE-MEZEI, Judith ARONHIME, Alexandr JEGOROV
  • Patent number: 8163913
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: April 24, 2012
    Assignee: Sicor Inc.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • Patent number: 8088919
    Abstract: Provided are crystalline forms of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid, pemetrexed diacid, and processes for the preparation thereof.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: January 3, 2012
    Assignee: Sicor Inc.
    Inventors: Jonathan Busolli, Nicola Diulgheroff, Csilla Nemethne Racz, Moran Pirkes, Alessandro Pontiroli, Marco Villa, Judith Aronhime
  • Patent number: 8080672
    Abstract: Provided is a crystal form of atorvastatin hemi-calcium and processes for its preparation.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: December 20, 2011
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Michael Pinchasov, Judith Aronhime, Zvika Doani